Darolutamide for non-metastatic castration-resistant prostate cancer: Efficacy, safety, and clinical perspectives of use-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Darolutamide for non-metastatic castration-resistant prostate cancer: Efficacy, safety, and clinical perspectives of use

Published:2023-04 Issue:4 Volume:122 Page:299-308
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Yang Cheng-Kuang,Cha Tai-Lung,Chang Yen-Hwa,Huang Shu-Pin,Lin Jen-Tai,Wang Shian-Shiang,Huang Chao-Yuan,Pang See-Tong

Funder

Kaohsiung Medical University Chung-Ho Memorial Hospital

Taipei Veterans General Hospital

Chung Shan Medical University

Tri-Service General Hospital

Kaohsiung Veterans General Hospital

Publisher

Elsevier BV

Subject

General Medicine

Reference80 articles.

1. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer;Cornford;Eur Urol,2021

2. Electronic address: clinicalguidelines@esmo.org. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Parker;Ann Oncol,2020

3. Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019;Gillessen;Eur Urol,2020

4. Mechanisms underlying the development of androgen-independent prostate cancer;Pienta;Clin Cancer Res,2006

5. Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer;Smith;Cancer,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics;Frontiers in Oncology;2023-08-17

2. Synthesis and Antitumor Activity of Panaxadiol Pyrazole and Isooxazole Derivatives;Chemistry & Biodiversity;2023-07-07

3. Highlights;Journal of the Formosan Medical Association;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3